Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03411811
Other study ID # UniversidadAI
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date October 1, 2018
Est. completion date January 2023

Study information

Verified date May 2021
Source Universidad Abierta Interamericana
Contact Miguel Slullitel, M.D.
Phone 0054 9 341 5012223
Email mslullitel@gmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Participants who have failed therapy for chronic wrist pain on the little finger side of the wrist will recieve dextrose prolotherapy. Their results will be compared to a cohort of consecutive participants who have not failed therapy, and receive 4 weeks of usual care.


Recruitment information / eligibility

Status Recruiting
Enrollment 60
Est. completion date January 2023
Est. primary completion date January 2022
Accepts healthy volunteers No
Gender All
Age group 21 Years to 70 Years
Eligibility Inclusion criteria - Pain on the ulnar side of the wrist. - PRWE greater than 40 Exclusion criteria - Radioulnar instability more than moderate as determined by a positive ulna fovea sign or ulna grinding test - Surgery in the wrist area - Infection in the wrist area - Other wrist pathology on examination - Other pain area that is constant, interferes with sleep, or is as bad, or worse, than shoulder pain. - Diabetes or other peripheral neuropathy - Radiculopathy - Unstable psychiatric function. - Current opioid use. - Vulnerable patients - Pregnancy

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Usual Care
Therapeutic ultrasound, myofascial release of extensor and flexor muscles of forearm and stabilization exercises for the wrist.
Procedure:
Dextrose
Injection of 1 ml of 12.5% dextrose in 1% lidocaine at 0, 3 and 6 weeks in 5 locations: Origin of ulnar collateral ligament, insertion of ulnar collateral ligament on the triquetrum, insertion of the extensor carpi ulnaris on the base of the 5th metacarpal, triquetral hamate ligament and ulnotriquetral joint space.

Locations

Country Name City State
Argentina Scanner Centro de Diagnostico Rosario Santa Fe

Sponsors (2)

Lead Sponsor Collaborator
Universidad Abierta Interamericana Gonzaolo Yaumauchi, M.D.

Country where clinical trial is conducted

Argentina, 

References & Publications (3)

Reeves KD, Sit RW, Rabago DP. Dextrose Prolotherapy: A Narrative Review of Basic Science, Clinical Research, and Best Treatment Recommendations. Phys Med Rehabil Clin N Am. 2016 Nov;27(4):783-823. doi: 10.1016/j.pmr.2016.06.001. Review. — View Citation

Spies CK, Müller LP, Oppermann J, Hahn P, Unglaub F. [Instability of the distal radioulnar joint - an overview of clinical and radiological procedures regarding their efficacies]. Handchir Mikrochir Plast Chir. 2014 Jun;46(3):137-50. doi: 10.1055/s-0033-1363662. Epub 2014 Feb 18. Review. German. — View Citation

Tay SC, Tomita K, Berger RA. The "ulnar fovea sign" for defining ulnar wrist pain: an analysis of sensitivity and specificity. J Hand Surg Am. 2007 Apr;32(4):438-44. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Change from Baseline PRWE (Patient Rated Wrist Evaluation) at 9 weeks The PRWE is a 15-item questionnaire designed to measure wrist pain and disability in activities of daily living. 9 weeks
Primary Change from baseline PRWE between 0 weeks and 1 year 1 year
Primary Percentage of participants exceeding a PRWE change of plus 14 between baseline and 9 weeks 9 weeks
Primary Percentage of participants exceeding a PRWE change of plus 14 between baseline and 1 year 1 year
Secondary Satisfaction score at 9 weeks On a scale from 1-5 please rate satisfaction with your results. 1 means 'no satisfaction' and 5 means 'complete satisfaction'. 9 weeks
Secondary Satisfaction score at 1 year On a scale from 1-5 please rate satisfaction with your results. 1 means 'no satisfaction' and 5 means 'complete satisfaction' 1 year